Abiopharma

🔍 Bedoya-Toro Munera Maria E (Executive)

Company: Dermata Therapeutics, Inc. (DRMA)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 9,000 shares of Stock Option (right to buy) at $2.18 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-01 | equity_swap_involved: 0 | shares_owned_after: 9,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The shares underlying the option will vest as to 25% upon the 12 month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12 month anniversary of the grant date.